AARD vs. SCHD
AARD (Aardvark Therapeutics, Inc) is a stock, while SCHD (Schwab U.S. Dividend Equity ETF) is Dividend fund tracking the Dow Jones U.S. Dividend 100 Index. Over the past year, AARD returned -45.43% vs 27.19% for SCHD. At a 0.17 correlation, their price movements are largely independent.
Performance
AARD vs. SCHD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AARD achieves a -51.77% return, which is significantly lower than SCHD's 22.44% return.
AARD
- 1D
- -5.10%
- 1M
- 70.16%
- 6M
- -58.76%
- YTD
- -51.77%
- 1Y
- -45.43%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SCHD
- 1D
- 2.16%
- 1M
- 2.38%
- 6M
- 15.69%
- YTD
- 22.44%
- 1Y
- 27.19%
- 3Y*
- 14.79%
- 5Y*
- 9.45%
- 10Y*
- 12.49%
AARD vs. SCHD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
AARD Aardvark Therapeutics, Inc | -51.77% | -13.54% |
SCHD Schwab U.S. Dividend Equity ETF | 22.44% | 3.10% |
Correlation
The correlation between AARD and SCHD is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Feb 13, 2025 | 0.17 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AARD vs. SCHD — Risk / Return Rank
AARD
SCHD
AARD vs. SCHD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aardvark Therapeutics, Inc (AARD) and Schwab U.S. Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AARD | SCHD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.84 | ||
| Sortino ratioReturn per unit of downside risk | -3.56 | ||
| Omega ratioGain probability vs. loss probability | 1.04 | 1.44 | -0.40 |
| Calmar ratioReturn relative to maximum drawdown | -0.57 | 5.92 | -6.49 |
| Martin ratioReturn relative to average drawdown | -0.92 | 14.46 | -15.38 |
Loading charts...
Drawdowns
AARD vs. SCHD - Drawdown Comparison
The maximum AARD drawdown since its inception was -80.01%, which is greater than SCHD's maximum drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for AARD and SCHD.
Loading charts...
Drawdown Indicators
| AARD | SCHD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -80.01% | -33.37% | -46.64% |
Max Drawdown (1Y)Largest decline over 1 year | -80.01% | -4.61% | -75.40% |
Max Drawdown (3Y)Largest decline over 3 years | — | -16.13% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -16.85% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.37% | — |
Current DrawdownCurrent decline from peak | -63.64% | 0.00% | -63.64% |
Average DrawdownAverage peak-to-trough decline | -43.03% | -3.30% | -39.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 49.67% | 1.89% | +47.78% |
Volatility
AARD vs. SCHD - Volatility Comparison
Aardvark Therapeutics, Inc (AARD) has a higher volatility of 56.07% compared to Schwab U.S. Dividend Equity ETF (SCHD) at 4.10%. This indicates that AARD's price experiences larger fluctuations and is considered to be riskier than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AARD | SCHD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 56.07% | 4.10% | +51.97% |
Volatility (6M)Calculated over the trailing 6-month period | 119.56% | 8.05% | +111.51% |
Volatility (1Y)Calculated over the trailing 1-year period | 123.54% | 11.04% | +112.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 122.50% | 14.40% | +108.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 122.50% | 16.71% | +105.79% |
Dividends
AARD vs. SCHD - Dividend Comparison
AARD has not paid dividends to shareholders, while SCHD's dividend yield for the trailing twelve months is around 3.17%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AARD Aardvark Therapeutics, Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SCHD Schwab U.S. Dividend Equity ETF | 3.17% | 3.82% | 3.64% | 3.49% | 3.39% | 2.78% | 3.16% | 2.98% | 3.06% | 2.63% | 2.89% | 2.97% |
Frequently Asked Questions
AARD and SCHD have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AARD has higher volatility (56.07%) compared to SCHD (4.10%). In terms of maximum drawdown, AARD dropped -80.01% vs SCHD's -33.37%.
SCHD currently has the higher Sharpe Ratio (2.47 vs -0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AARD and SCHD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer